Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav … – Investors
Jazz Pharmaceuticals continues pharmaceutical CBD research with new presentations on Epidiolex. These studies focus on expanding evidence-based cannabinoid medicine beyond approved epilepsy indications. Pharmaceutical CBD research informs off-label…
FDA Grants Limited Enforcement Discretion for CBD in Dietary Supplements
FDA enforcement discretion CBD policy marks a new regulated pathway for dietary supplements in the U.S. This shift may improve product quality oversight and patient access. Clinicians should understand these changes to guide patient care effectively.
Impact of CBD and Hemp Oil Use on Drug Test Results: A Systematic Review
Drug testing CBD hemp products is a common concern for patients considering CBD therapy. This systematic review provides evidence-based guidance on drug test risks associated with CBD and hemp oil use. Understanding these risks helps clinicians counsel…
Moving Crest LLC Cannabidiol Capsules: Beyond Stress and Pain Benefits
Commercial CBD products health claims require careful clinical scrutiny. This article reviews cannabidiol capsules and their potential benefits beyond stress and pain. Understanding the evidence gap helps clinicians guide patients effectively.
WCN26-5407 Pharmacokinetics of Cannabidiol in People with Kidney Failure
This article reviews pharmacokinetics cannabidiol kidney failure, highlighting important clinical considerations. Understanding CBD metabolism in kidney failure is critical for safe cannabis medicine use. Clinicians should monitor emerging evidence on…
Anticancer Potential of Cannabidiol in Renal Cell Carcinoma: Serum Modulation and Preliminary Mechanistic Insights.
This study explores the anticancer potential cannabidiol renal cell carcinoma effects through serum modulation. Preliminary mechanistic insights provide a foundation for further research. The findings highlight the need for cautious interpretation in…
CED Cannabis Research Digest — February 27, 2026
The cannabis medicine research digest for February 27, 2026, highlights key peer-reviewed studies scored for clinical relevance. This weekly digest provides a curated summary of cannabis research to inform patient care. Stay updated with the latest…
CBD and Liver Enzymes: What the New JAMA Study Actually Shows
The CBD liver enzyme elevation study published in JAMA 2025 provides new insights into how high-dose CBD affects liver enzymes. This study highlights that enzyme elevations are often temporary and asymptomatic. Understanding these findings helps clarify…
5 Surprising Benefits of Cannabidiol Anxiety Treatment
Exploring the Benefits and Safety of Nano-particle CBD for Anxiety Treatment What is this All About? Anxiety disorders are some of the most common mental health issues around the world. In 2019, about 301 million people were affected by these conditions.…
5 Ways Cannabidiol Supports Neuroprotection in Alzheimer’s
Cannabidiol Alzheimer’s neuroprotection offers promising benefits for brain health by reducing neuroinflammation and oxidative stress. This treatment supports cognitive decline prevention in Alzheimer’s disease. Discover how cannabidiol influences key…
